Sign in

CIK 0001326190

  • Non-accelerated filer
  • Smaller reporting company

Altimmune, Inc.

Sign in to watch
Ticker
ALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
202726770
Phone
+1 862-457-1450
Business address
350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
Former names
PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 4 Shares withheld for taxes Chief Financial Officer gave up 3,028 shares (to pay taxes)
  7. 4 Open-market sale Director sold 20,000 shares at $15.01 ($300,268)
  8. 4 Shares withheld for taxes President and CEO gave up 3,007 shares (to pay taxes)
  9. 4 Option exercise Director acquired 139 shares (option exercise)
  10. 4 Shares withheld for taxes President and CEO gave up 3,007 shares (to pay taxes)
  11. 4 Shares withheld for taxes President and CEO gave up 3,008 shares (to pay taxes)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Open-market sale President and CEO sold 20,000 shares at $20.02 ($400,322)
  20. 4 Open-market sale President and CEO sold 15,000 shares at $15.06 ($225,890)

Page 8 of 34 · 674 filings